Clinical Trials Browser

INDUSTRY × Leukemia, Myeloid, Acute × Fibroblast Growth Factor 7 × Clear all

NCT00460421 2014-12-05

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

Phase 1 Completed

27 enrolled 19 charts

LymphoidOther hematologic neoplasm

Leukemia, Stomatitis, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma